Col NF - Search Results

1

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Chlebowski RT, Pan K, Col NF. Chlebowski RT, et al. Among authors: col nf. Breast Cancer Res Treat. 2017 Jan;161(2):185-190. doi: 10.1007/s10549-016-4024-4. Epub 2016 Oct 26. Breast Cancer Res Treat. 2017. PMID: 27785653 Review.

2

Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.

Chlebowski RT, Haque R, Hedlin H, Col N, Paskett E, Manson JE, Kubo JT, Johnson KC, Wactawski-Wende J, Pan K, Anderson G. Chlebowski RT, et al. Breast Cancer Res Treat. 2015 Dec;154(3):609-16. doi: 10.1007/s10549-015-3647-1. Epub 2015 Nov 24. Breast Cancer Res Treat. 2015. PMID: 26602222

3

Metformin and breast cancer risk: a meta-analysis and critical literature review.

Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT. Col NF, et al. Breast Cancer Res Treat. 2012 Oct;135(3):639-46. doi: 10.1007/s10549-012-2170-x. Epub 2012 Jul 31. Breast Cancer Res Treat. 2012. PMID: 22847511 Review.

4

Menopausal hormone therapy after breast cancer.

Chlebowski RT, Col N. Chlebowski RT, et al. Lancet. 2004 Feb 7;363(9407):410-1. doi: 10.1016/S0140-6736(04)15519-0. Lancet. 2004. PMID: 14962515 No abstract available.

5

Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use.

Chlebowski RT, Anderson GL, Geller M, Col N. Chlebowski RT, et al. Clin Breast Cancer. 2006 Feb;6 Suppl 2:S58-64. doi: 10.3816/cbc.2006.s.005. Clin Breast Cancer. 2006. PMID: 16595028 Review.

6

Bisphosphonates and breast cancer prevention.

Chlebowski RT, Col N. Chlebowski RT, et al. Anticancer Agents Med Chem. 2012 Feb;12(2):144-50. doi: 10.2174/187152012799014913. Anticancer Agents Med Chem. 2012. PMID: 21864227 Review.

7

Bisphosphonates and breast cancer incidence and recurrence.

Chlebowski RT, Col N. Chlebowski RT, et al. Breast Dis. 2011;33(2):93-101. doi: 10.3233/BD-2010-0324. Breast Dis. 2011. PMID: 22142660 Review.

8

Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.

Chlebowski RT, Col N. Chlebowski RT, et al. Breast J. 2012 Jul-Aug;18(4):299-302. doi: 10.1111/j.1524-4741.2012.01267.x. Epub 2012 Jun 11. Breast J. 2012. PMID: 22681627

9

Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy.

Chlebowski RT, Kim JA, Col NF. Chlebowski RT, et al. Among authors: col nf. Semin Oncol. 2003 Dec;30(6):776-88. doi: 10.1053/j.seminoncol.2003.08.021. Semin Oncol. 2003. PMID: 14663778 Review.

10

Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence.

Col NF, Kim JA, Chlebowski RT. Col NF, et al. Breast Cancer Res. 2005;7(4):R535-40. doi: 10.1186/bcr1035. Epub 2005 May 19. Breast Cancer Res. 2005. PMID: 15987460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters